4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
VivoSim Labs, Inc. (VIVS) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 14 employees. Its market capitalization is roughly $2 million. In the fiscal year ended 2025-03-31, VIVS reported $0M in revenue and ($2M) in net income.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine.
Interactive charts & full statements → Open the VIVS valuation workbench →
| Income statement | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $2M |
| Gross Profit | $0M | $0M | — | — |
| Operating Income (EBIT) | ($13M) | ($15M) | ($18M) | ($12M) |
| Net Income | ($2M) | ($15M) | ($17M) | ($11M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($3M) | ($3M) | ($3M) | ($3M) | ($4M) |
| Net Income | ($3M) | ($2M) | ($3M) | $7M | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| Total Assets | $15M | $6M | $20M | $33M |
| Total Liabilities | $4M | $3M | $5M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VIVS viewer.
About TickerBase · Data methodology & sources